[1]
Tjia KF, van Putten JP, Pels E, Zanen HC. The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 1988:226(4):341-5
[PubMed PMID: 3139497]
[2]
Mendoza L, Hernandez F, Ajello L. Life cycle of the human and animal oomycete pathogen Pythium insidiosum. Journal of clinical microbiology. 1993 Nov:31(11):2967-73
[PubMed PMID: 8263182]
Level 3 (low-level) evidence
[3]
Tondolo JSM, Ledur PC, Loreto ÉS, Verdi CM, Bitencourt PER, de Jesus FPK, Rocha JP, Alves SH, Sassaki GL, Santurio JM. Extraction, characterization and biological activity of a (1,3)(1,6)-β-d-glucan from the pathogenic oomycete Pythium insidiosum. Carbohydrate polymers. 2017 Feb 10:157():719-727. doi: 10.1016/j.carbpol.2016.10.053. Epub 2016 Oct 19
[PubMed PMID: 27987983]
[4]
Ladas JG, Mondino BJ. Systemic disorders associated with peripheral corneal ulceration. Current opinion in ophthalmology. 2000 Dec:11(6):468-71
[PubMed PMID: 11141643]
Level 3 (low-level) evidence
[5]
Jeng BH, Gritz DC, Kumar AB, Holsclaw DS, Porco TC, Smith SD, Whitcher JP, Margolis TP, Wong IG. Epidemiology of ulcerative keratitis in Northern California. Archives of ophthalmology (Chicago, Ill. : 1960). 2010 Aug:128(8):1022-8. doi: 10.1001/archophthalmol.2010.144. Epub
[PubMed PMID: 20697003]
[6]
Srinivasan M, Gonzales CA, George C, Cevallos V, Mascarenhas JM, Asokan B, Wilkins J, Smolin G, Whitcher JP. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. The British journal of ophthalmology. 1997 Nov:81(11):965-71
[PubMed PMID: 9505820]
[7]
Hill GM, Ku ES, Dwarakanathan S. Herpes simplex keratitis. Disease-a-month : DM. 2014 Jun:60(6):239-46. doi: 10.1016/j.disamonth.2014.03.003. Epub
[PubMed PMID: 24906668]
[8]
Liesegang TJ. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Archives of ophthalmology (Chicago, Ill. : 1960). 1989 Aug:107(8):1160-5
[PubMed PMID: 2757546]
[9]
Galor A,Thorne JE, Scleritis and peripheral ulcerative keratitis. Rheumatic diseases clinics of North America. 2007 Nov
[PubMed PMID: 18037120]
[10]
Moore DB, Shirefaw W, Tomkins-Netzer O, Eshete Z, Netzer-Tomkins H, Ben-Zion I. Prevalence of xerophthalmia among malnourished children in rural Ethiopia. International ophthalmology. 2013 Oct:33(5):455-9. doi: 10.1007/s10792-013-9715-9. Epub 2013 Jan 25
[PubMed PMID: 23354453]
[11]
Kenyon KR. Inflammatory mechanisms in corneal ulceration. Transactions of the American Ophthalmological Society. 1985:83():610-63
[PubMed PMID: 3914132]
[12]
Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infection and drug resistance. 2018:11():981-993. doi: 10.2147/IDR.S162669. Epub 2018 Jul 17
[PubMed PMID: 30046247]
[13]
Dana MR,Qian Y,Hamrah P, Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000 Sep
[PubMed PMID: 11009315]
Level 2 (mid-level) evidence
[14]
DeCroos FC, Garg P, Reddy AK, Sharma A, Krishnaiah S, Mungale M, Mruthyunjaya P, Hyderabad Endophthalmitis Research Group. Optimizing diagnosis and management of nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview. Ophthalmology. 2011 Jun:118(6):1193-200. doi: 10.1016/j.ophtha.2010.10.037. Epub 2011 Jan 26
[PubMed PMID: 21276615]
Level 3 (low-level) evidence
[15]
Sridhar MS, Gopinathan U, Garg P, Sharma S, Rao GN. Ocular nocardia infections with special emphasis on the cornea. Survey of ophthalmology. 2001 Mar-Apr:45(5):361-78
[PubMed PMID: 11274691]
Level 3 (low-level) evidence
[16]
Ko J, Kim SK, Yong DE, Kim TI, Kim EK. Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review. Medicine. 2017 Dec:96(51):e9356. doi: 10.1097/MD.0000000000009356. Epub
[PubMed PMID: 29390522]
Level 3 (low-level) evidence
[17]
John T,Velotta E, Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications. Cornea. 2005 Apr;
[PubMed PMID: 15778593]
[18]
Moorthy RS, Valluri S, Rao NA. Nontuberculous mycobacterial ocular and adnexal infections. Survey of ophthalmology. 2012 May-Jun:57(3):202-35. doi: 10.1016/j.survophthal.2011.10.006. Epub
[PubMed PMID: 22516536]
Level 3 (low-level) evidence
[19]
Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature. BioMed research international. 2015:2015():164989. doi: 10.1155/2015/164989. Epub 2015 May 27
[PubMed PMID: 26106601]
Level 1 (high-level) evidence
[20]
Omari AA,Mian SI, Adenoviral keratitis: a review of the epidemiology, pathophysiology, clinical features, diagnosis, and management. Current opinion in ophthalmology. 2018 Jul;
[PubMed PMID: 29708932]
Level 3 (low-level) evidence
[21]
Mader TH, Stulting RD. Viral keratitis. Infectious disease clinics of North America. 1992 Dec:6(4):831-49
[PubMed PMID: 1334105]
[22]
Bialasiewicz A. Adenoviral keratoconjunctivitis. Sultan Qaboos University medical journal. 2007 Apr:7(1):15-23
[PubMed PMID: 21654940]
[23]
Akkaya S, Ozkurt YB. Persistent Symblepharon in an Infant Following Epidemic Keratoconjunctivitis. Medical hypothesis, discovery & innovation ophthalmology journal. 2016 Fall:5(3):74-77
[PubMed PMID: 28293652]
[24]
Hammer LH,Perry HD,Donnenfeld ED,Rahn EK, Symblepharon formation in epidemic keratoconjunctivitis. Cornea. 1990 Oct
[PubMed PMID: 2078963]
[25]
Shoji J, Sakimoto T, Inada N, Kamei Y, Matsubara M, Takamura E, Sawa M. A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation. Japanese journal of ophthalmology. 2016 Jul:60(4):294-301. doi: 10.1007/s10384-016-0448-y. Epub 2016 Apr 28
[PubMed PMID: 27126382]
[26]
Chang EJ, Dreyer EB. Herpesvirus infections of the anterior segment. International ophthalmology clinics. 1996 Summer:36(3):17-28
[PubMed PMID: 8989597]
[27]
Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. The Cochrane database of systematic reviews. 2015 Jan 9:1(1):CD002898. doi: 10.1002/14651858.CD002898.pub5. Epub 2015 Jan 9
[PubMed PMID: 25879115]
Level 1 (high-level) evidence
[28]
Souza PM, Holland EJ, Huang AJ. Bilateral herpetic keratoconjunctivitis. Ophthalmology. 2003 Mar:110(3):493-6
[PubMed PMID: 12623810]
[29]
Holbach LM, Font RL, Naumann GO. Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer. Ophthalmology. 1990 Jun:97(6):722-8
[PubMed PMID: 2165231]
[30]
McGill J. The enigma of herpes stromal disease. The British journal of ophthalmology. 1987 Feb:71(2):118-25
[PubMed PMID: 3548807]
[31]
Dutt S, Acharya M, Gour A, Sapra N, Chauhan L, Mathur U. Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis. Indian journal of ophthalmology. 2016 Apr:64(4):292-5. doi: 10.4103/0301-4738.182940. Epub
[PubMed PMID: 27221681]
[32]
Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Medical hypothesis, discovery & innovation ophthalmology journal. 2015 Winter:4(4):142-156
[PubMed PMID: 27800502]
[33]
Li JY. Herpes zoster ophthalmicus: acute keratitis. Current opinion in ophthalmology. 2018 Jul:29(4):328-333. doi: 10.1097/ICU.0000000000000491. Epub
[PubMed PMID: 29794881]
Level 3 (low-level) evidence
[34]
Hu AY, Strauss EC, Holland GN, Chan MF, Yu F, Margolis TP. Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus. American journal of ophthalmology. 2010 Feb:149(2):214-220.e3. doi: 10.1016/j.ajo.2009.08.030. Epub 2009 Nov 11
[PubMed PMID: 19909942]
[35]
Davis AR, Sheppard J. Herpes Zoster Ophthalmicus Review and Prevention. Eye & contact lens. 2019 Sep:45(5):286-291. doi: 10.1097/ICL.0000000000000591. Epub
[PubMed PMID: 30844951]
[36]
Maycock NJ, Jayaswal R. Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes. Cornea. 2016 May:35(5):713-20. doi: 10.1097/ICO.0000000000000804. Epub
[PubMed PMID: 26989955]
[37]
Lorenzo-Morales J,Khan NA,Walochnik J, An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite (Paris, France). 2015;
[PubMed PMID: 25687209]
[38]
Sharma S, Balne PK, Motukupally SR, Das S, Garg P, Sahu SK, Arunasri K, Manjulatha K, Mishra DK, Shivaji S. Pythium insidiosum keratitis: clinical profile and role of DNA sequencing and zoospore formation in diagnosis. Cornea. 2015 Apr:34(4):438-42. doi: 10.1097/ICO.0000000000000349. Epub
[PubMed PMID: 25738236]
[39]
Vossbrinck CR, Maddox JV, Friedman S, Debrunner-Vossbrinck BA, Woese CR. Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature. 1987 Mar 26-Apr 1:326(6111):411-4
[PubMed PMID: 3550472]
[40]
Weiss LM, Edlind TD, Vossbrinck CR, Hashimoto T. Microsporidian molecular phylogeny: the fungal connection. The Journal of eukaryotic microbiology. 1999 Sep-Oct:46(5):17S-18S
[PubMed PMID: 10519229]
[41]
Capella-Gutiérrez S,Marcet-Houben M,Gabaldón T, Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi. BMC biology. 2012 May 31
[PubMed PMID: 22651672]
[42]
Sridhar MS, Sharma S. Microsporidial keratoconjunctivitis in a HIV-seronegative patient treated with debridement and oral itraconazole. American journal of ophthalmology. 2003 Oct:136(4):745-6
[PubMed PMID: 14516821]
[43]
Joseph J, Sridhar MS, Murthy S, Sharma S. Clinical and microbiological profile of microsporidial keratoconjunctivitis in southern India. Ophthalmology. 2006 Apr:113(4):531-7
[PubMed PMID: 16488011]
[44]
Moon SJ, Mann PM, Matoba AY. Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery. Cornea. 2003 Apr:22(3):271-2
[PubMed PMID: 12658099]
[45]
Das S,Sharma S,Sahu SK,Nayak SS,Kar S, New microbial spectrum of epidemic keratoconjunctivitis: clinical and laboratory aspects of an outbreak. The British journal of ophthalmology. 2008 Jun;
[PubMed PMID: 18523092]
[46]
Reddy AK, Balne PK, Garg P, Krishnaiah S. Is microsporidial keratitis a seasonal infection in India? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011 Jul:17(7):1114-6. doi: 10.1111/j.1469-0691.2010.03084.x. Epub
[PubMed PMID: 21726353]
[47]
Loh RS, Chan CM, Ti SE, Lim L, Chan KS, Tan DT. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology. 2009 Dec:116(12):2348-53. doi: 10.1016/j.ophtha.2009.05.004. Epub 2009 Oct 7
[PubMed PMID: 19815287]
[48]
Tung-Lien Quek D, Pan JC, Krishnan PU, Zhao PS, Teoh SC. Microsporidial keratoconjunctivitis in the tropics: a case series. The open ophthalmology journal. 2011:5():42-7. doi: 10.2174/1874364101105010042. Epub 2011 May 17
[PubMed PMID: 21643428]
Level 2 (mid-level) evidence
[49]
Pinnolis M, Egbert PR, Font RL, Winter FC. Nosematosis of the cornea. Case report, including electron microscopic studies. Archives of ophthalmology (Chicago, Ill. : 1960). 1981 Jun:99(6):1044-7
[PubMed PMID: 6786272]
Level 3 (low-level) evidence
[50]
Vemuganti GK, Garg P, Sharma S, Joseph J, Gopinathan U, Singh S. Is microsporidial keratitis an emerging cause of stromal keratitis? A case series study. BMC ophthalmology. 2005 Aug 17:5():19
[PubMed PMID: 16105181]
Level 2 (mid-level) evidence
[51]
Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc. 1997 Oct:23(4):275-81
[PubMed PMID: 9348453]
Level 2 (mid-level) evidence
[52]
Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006 Apr:113(4):526-30
[PubMed PMID: 16581414]
[53]
Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology. 2000 Mar:107(3):574-80
[PubMed PMID: 10711898]
[54]
Rice NS, Jones BR. Vernal kerato-conjunctivitis: an allergic disease of the eyes of children. Clinical allergy. 1973 Dec:3 Suppl():629-37
[PubMed PMID: 4220246]
[55]
Bhalerao SA,Singh P,Rani PK,Rathi V, The sting of a honey bee: An unusual subconjunctival foreign body. Indian journal of ophthalmology. 2017 Nov;
[PubMed PMID: 29133661]
[56]
Itty S, Pulido JS, Bakri SJ, Baratz KH, Matteson EL, Hodge DO. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis. Transactions of the American Ophthalmological Society. 2008:106():75-81; discussion 81-3
[PubMed PMID: 19277223]
[57]
Singh P, Kumar A, Chandra P. Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic. Indian journal of ophthalmology. 2020 Jan:68(1):236-238. doi: 10.4103/ijo.IJO_526_19. Epub
[PubMed PMID: 31856537]
[58]
Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983 Mar:90(3):279-90
[PubMed PMID: 6602963]
[59]
Cao Y, Zhang W, Wu J, Zhang H, Zhou H. Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment. Journal of ophthalmology. 2017:2017():7298026. doi: 10.1155/2017/7298026. Epub 2017 Jul 13
[PubMed PMID: 28785483]
[60]
Říhová E, Svozílková P, Brichová M, Klímová A, Kuthan P, Diblík P. Ocular Manifestations of Granulomatosis with Polyangiitis. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2019 Spring:74(5):167-174. doi: 10.31348/2018/5/1. Epub
[PubMed PMID: 31234629]
[61]
Bluestone R. Bridge collapse followed by joint pains, nephritis. Hospital practice (Office ed.). 1983 Aug:18(8):58L, 58P
[PubMed PMID: 6409795]
[62]
Khor WB,Prajna VN,Garg P,Mehta JS,Xie L,Liu Z,Padilla MDB,Joo CK,Inoue Y,Goseyarakwong P,Hu FR,Nishida K,Kinoshita S,Puangsricharern V,Tan AL,Beuerman R,Young A,Sharma N,Haaland B,Mah FS,Tu EY,Stapleton FJ,Abbott RL,Tan DT, The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia. American journal of ophthalmology. 2018 Nov;
[PubMed PMID: 30098351]
Level 2 (mid-level) evidence
[63]
Gupta N, Tandon R. Investigative modalities in infectious keratitis. Indian journal of ophthalmology. 2008 May-Jun:56(3):209-13
[PubMed PMID: 18417821]
[64]
Garg P. Investigative modalities in infectious keratitis. Indian journal of ophthalmology. 2009 Mar-Apr:57(2):159
[PubMed PMID: 19237797]
[65]
Sharma V,Sharma S,Garg P,Rao GN, Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy. Indian journal of ophthalmology. 2004 Dec
[PubMed PMID: 15693319]
[66]
McElvanney AM. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature. Eye & contact lens. 2003 Oct:29(4):258-61
[PubMed PMID: 14555906]
Level 3 (low-level) evidence
[67]
Chatterjee S, Agrawal D. Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Indian journal of ophthalmology. 2016 Feb:64(2):153-7. doi: 10.4103/0301-4738.179721. Epub
[PubMed PMID: 27050354]
[68]
Garg P. Fungal, Mycobacterial, and Nocardia infections and the eye: an update. Eye (London, England). 2012 Feb:26(2):245-51. doi: 10.1038/eye.2011.332. Epub 2011 Dec 16
[PubMed PMID: 22173077]
[69]
Sridhar MS, Sharma S, Reddy MK, Mruthyunjay P, Rao GN. Clinicomicrobiological review of Nocardia keratitis. Cornea. 1998 Jan:17(1):17-22
[PubMed PMID: 9436875]
[70]
Lalitha P,Srinivasan M,Rajaraman R,Ravindran M,Mascarenhas J,Priya JL,Sy A,Oldenburg CE,Ray KJ,Zegans ME,McLeod SD,Lietman TM,Acharya NR, Nocardia keratitis: clinical course and effect of corticosteroids. American journal of ophthalmology. 2012 Dec;
[PubMed PMID: 22959881]
[71]
Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Piñero JE, Valladares B. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends in parasitology. 2013 Apr:29(4):181-7. doi: 10.1016/j.pt.2013.01.006. Epub 2013 Feb 21
[PubMed PMID: 23433689]
[72]
Tu EY, Shoff ME, Gao W, Joslin CE. Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis. JAMA ophthalmology. 2013 May:131(5):595-600. doi: 10.1001/jamaophthalmol.2013.1644. Epub
[PubMed PMID: 23519403]
[73]
Nakagawa H, Hattori T, Koike N, Ehara T, Narimatsu A, Kumakura S, Matsumoto T, Goto H. Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis. Cornea. 2017 Mar:36(3):353-357. doi: 10.1097/ICO.0000000000001129. Epub
[PubMed PMID: 28079686]
[74]
Nakagawa H, Hattori T, Koike N, Ehara T, Fujita K, Takahashi H, Kumakura S, Kuroda M, Matsumoto T, Goto H. Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis. Cornea. 2015 Oct:34(10):1308-15. doi: 10.1097/ICO.0000000000000541. Epub
[PubMed PMID: 26203748]
[75]
Mittal R, Jena SK, Desai A, Agarwal S. Pythium Insidiosum Keratitis: Histopathology and Rapid Novel Diagnostic Staining Technique. Cornea. 2017 Sep:36(9):1124-1132. doi: 10.1097/ICO.0000000000001244. Epub
[PubMed PMID: 28582375]
[76]
Ramappa M, Nagpal R, Sharma S, Chaurasia S. Successful Medical Management of Presumptive Pythium insidiosum Keratitis. Cornea. 2017 Apr:36(4):511-514. doi: 10.1097/ICO.0000000000001162. Epub
[PubMed PMID: 28207431]
[77]
Bagga B, Sharma S, Madhuri Guda SJ, Nagpal R, Joseph J, Manjulatha K, Mohamed A, Garg P. Leap forward in the treatment of Pythium insidiosum keratitis. The British journal of ophthalmology. 2018 Dec:102(12):1629-1633. doi: 10.1136/bjophthalmol-2017-311360. Epub 2018 Mar 15
[PubMed PMID: 29545414]
[78]
Loreto ES,Tondolo JS,Pilotto MB,Alves SH,Santurio JM, New insights into the in vitro susceptibility of Pythium insidiosum. Antimicrobial agents and chemotherapy. 2014 Dec;
[PubMed PMID: 25223997]
Level 3 (low-level) evidence
[79]
Sanjay S. Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis. American journal of ophthalmology. 2011 Jan:151(1):183; author reply 183. doi: 10.1016/j.ajo.2010.08.029. Epub
[PubMed PMID: 21163375]
[80]
Das S, Wallang BS, Sharma S, Bhadange YV, Balne PK, Sahu SK. The efficacy of corneal debridement in the treatment of microsporidial keratoconjunctivitis: a prospective randomized clinical trial. American journal of ophthalmology. 2014 Jun:157(6):1151-5. doi: 10.1016/j.ajo.2014.02.050. Epub 2014 Feb 28
[PubMed PMID: 24589573]
Level 1 (high-level) evidence
[81]
Font RL, Samaha AN, Keener MJ, Chevez-Barrios P, Goosey JD. Corneal microsporidiosis. Report of case, including electron microscopic observations. Ophthalmology. 2000 Sep:107(9):1769-75
[PubMed PMID: 10964843]
Level 3 (low-level) evidence
[82]
Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ. Therapeutic strategies for human microsporidia infections. Expert review of anti-infective therapy. 2005 Jun:3(3):419-34
[PubMed PMID: 15954858]
[83]
Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA ophthalmology. 2013 Apr:131(4):422-9
[PubMed PMID: 23710492]
Level 1 (high-level) evidence
[84]
Prajna NV, Krishnan T, Rajaraman R, Patel S, Srinivasan M, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial II Group. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial. JAMA ophthalmology. 2016 Dec 1:134(12):1365-1372. doi: 10.1001/jamaophthalmol.2016.4096. Epub
[PubMed PMID: 27787540]
Level 1 (high-level) evidence
[85]
Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Devi L, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II. JAMA ophthalmology. 2017 Jun 1:135(6):520-525. doi: 10.1001/jamaophthalmol.2017.0616. Epub
[PubMed PMID: 28426856]
[86]
Sharma N, Sahay P, Maharana PK, Singhal D, Saluja G, Bandivadekar P, Chako J, Agarwal T, Sinha R, Titiyal JS, Satpathy G, Velpandian T. Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol. Cornea. 2019 Feb:38(2):141-145. doi: 10.1097/ICO.0000000000001781. Epub
[PubMed PMID: 30334872]
[87]
Darougar S,Wishart MS,Viswalingam ND, Epidemiological and clinical features of primary herpes simplex virus ocular infection. The British journal of ophthalmology. 1985 Jan;
[PubMed PMID: 3965025]
Level 2 (mid-level) evidence
[88]
Koizumi N, Nishida K, Adachi W, Tei M, Honma Y, Dota A, Sotozono C, Yokoi N, Yamamoto S, Kinoshita S. Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction. The British journal of ophthalmology. 1999 Aug:83(8):957-60
[PubMed PMID: 10413702]
[89]
. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. Archives of ophthalmology (Chicago, Ill. : 1960). 2000 Aug:118(8):1030-6
[PubMed PMID: 10922194]
[90]
Wu X, Chen X. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis. Chinese medical journal. 2002 Oct:115(10):1569-72
[PubMed PMID: 12490113]
[91]
Hoang-Xuan T, Büchi ER, Herbort CP, Denis J, Frot P, Thénault S, Pouliquen Y. Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology. 1992 Jul:99(7):1062-70; discussion 1070-1
[PubMed PMID: 1495785]
[92]
Reichstein JB, Patel V, Mekaroonkamol P, Dacha S, Keilin SA, Cai Q, Willingham FF. Practice Patterns and Use of Endoscopic Retrograde Cholangiopancreatography in the Management of Recurrent Acute Pancreatitis. Clinical endoscopy. 2020 Jan:53(1):73-81. doi: 10.5946/ce.2019.052. Epub 2019 Jul 5
[PubMed PMID: 31273969]
[93]
Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, Mandelboim M. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta ophthalmologica. 2017 Dec:95(8):e686-e692. doi: 10.1111/aos.13416. Epub 2017 Mar 25
[PubMed PMID: 28342227]
Level 1 (high-level) evidence
[94]
Asena L, Şıngar Özdemir E, Burcu A, Ercan E, Çolak M, Altınörs DD. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye (London, England). 2017 May:31(5):781-787. doi: 10.1038/eye.2017.4. Epub 2017 Feb 3
[PubMed PMID: 28157224]
Level 2 (mid-level) evidence
[95]
Sakarya Y, Sakarya R, Yildirim A. Electrolysis treatment of trichiasis by using ultra-fine needle. European journal of ophthalmology. 2010 Jul-Aug:20(4):664-8
[PubMed PMID: 20037913]
[96]
Anderson RL,Harvey JT, Lid splitting and posterior lamella cryosurgery for congenital and acquired distichiasis. Archives of ophthalmology (Chicago, Ill. : 1960). 1981 Apr;
[PubMed PMID: 7224935]
[97]
Kumar S. Combined therapy for vernal shield ulcer. Clinical & experimental optometry. 2008 Jan:91(1):111-4
[PubMed PMID: 18045257]
[98]
Singh S, Pal V, Dhull CS. Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian journal of ophthalmology. 2001 Dec:49(4):241-5
[PubMed PMID: 12930116]
[99]
Nishiwaki-Dantas MC, Dantas PE, Pezzutti S, Finzi S. Surgical resection of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae. Ophthalmic plastic and reconstructive surgery. 2000 Nov:16(6):438-42
[PubMed PMID: 11106188]
[100]
Iyer G,Agarwal S,Srinivasan B, Outcomes and Rationale of Excision and Mucous Membrane Grafting in Palpebral Vernal Keratoconjunctivitis. Cornea. 2018 Feb;
[PubMed PMID: 29040121]
[101]
El-Banna H, Jiman-Fatani A. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC musculoskeletal disorders. 2014 Nov 19:15():379. doi: 10.1186/1471-2474-15-379. Epub 2014 Nov 19
[PubMed PMID: 25406539]
[102]
Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis and rheumatism. 2004 Feb:50(2):380-6
[PubMed PMID: 14872479]
[103]
Weinblatt ME. Methotrexate in rheumatoid arthritis: a quarter century of development. Transactions of the American Clinical and Climatological Association. 2013:124():16-25
[PubMed PMID: 23874006]
[104]
Bernauer W,Ficker LA,Watson PG,Dart JK, The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes. Ophthalmology. 1995 Sep;
[PubMed PMID: 9097770]
[105]
Lohchab M, Prakash G, Arora T, Maharana P, Jhanji V, Sharma N, Vajpayee RB. Surgical management of peripheral corneal thinning disorders. Survey of ophthalmology. 2019 Jan-Feb:64(1):67-78. doi: 10.1016/j.survophthal.2018.06.002. Epub 2018 Jun 8
[PubMed PMID: 29886126]
Level 3 (low-level) evidence
[106]
Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Survey of ophthalmology. 2010 Sep-Oct:55(5):429-44. doi: 10.1016/j.survophthal.2009.12.003. Epub 2010 Jul 17
[PubMed PMID: 20638092]
Level 3 (low-level) evidence
[107]
De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. The Biochemical journal. 2005 Sep 1:390(Pt 2):407-18
[PubMed PMID: 15859953]
[108]
Brandt CR, Peptide therapeutics for treating ocular surface infections. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2014 Nov;
[PubMed PMID: 25250986]